RAYMOND MUSCI

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Protagenic Therapeutics, Inc.\new

Filing Date Source Excerpt
2009-05-26 Raymond Musci 49 Executive Vice President, Corporate Development and Director
2010-10-25 The undersigned, a stockholder of ATRINSIC, INC., hereby nominates, constitutes and appoints Raymond Musci and Thomas Plotts, or either one of them, as proxy of the undersigned...

Data sourced from SEC filings. Last updated: 2026-03-05